Walgreens Boots Alliance (WBA) has agreed to pay Humana (HUM) $360M to settle a drug-pricing dispute, The Wall Street Journal’s Will Feuer reports. The lawsuit alleged the retail-pharmacy chain overcharged for prescription-drug reimbursements. Walgreens had asked a federal court to vacate a previous award in Humana’s favor for $642M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on WBA:
- Walgreens Stock (NASDAQ:WBA): Dividend Slashed after 47 Years. Blessing in Disguise?
- Walgreens Boots Alliance Inc. Earnings Update: Did it Beat Estimate Forecasts?
- Walgreens Stock (NASDAQ:WBA): Consider Taking Action on the Market’s Wrong Reaction
- Walgreens (NASDAQ:WBA) Beats Q1 Earnings Estimates but Slashes Dividend
- Walgreens Boots Alliance reduces quarterly dividend 48% to 25c per share